This page shows the details of why an item matched the keywords from your search.
Property | Value |
has major subject area list
|
Antineoplastic Agents; Prostatic Neoplasms; Pyrimidines; Sulfonamides
|
information resource reference
|
A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study. Prostate Cancer Prostatic Dis. 2012 Mar; 15(1):87-92.
|
label
|
A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study.
|